Pablo Corral Shares New Insights: Genome Editing and Gene Therapy for Lipid Disorders
Pablo Corral, Past President of Argentine Lipid Society, has shared a post on LinkedIn:
“A must read article
‘Gene therapy and genome editing for lipoprotein disorders‘ provides a comprehensive and timely overview of how advances in genetic medicine—including AAV gene addition, CRISPR editing, and RNA-based strategies—are reshaping the prevention and management of dyslipidaemias and ASCVD.
This open-access article highlights how innovative approaches may overcome limitations of lifelong lipid-lowering therapy, address unmet clinical needs in familial and polygenic disorders, and integrate polygenic risk scores and machine learning to personalize cardiovascular prevention.
An excellent resource for clinicians, researchers, and students interested in the rapidly evolving field of cardiovascular genetics.”
Title: Gene therapy and genome editing for lipoprotein disorders
Authors: Chen Gurevitz, Archna Bajaj, Amit V Khera, Ron Do, Heribert Schunkert, Kiran Musunuru, Robert S Rosenson
Read the full paper here.
Stay informed with Hemostasis Today.
-
Jan 11, 2026, 03:55Building Better Care for Bleeding Disorders in Zambia․ Chatowa’s Journey
-
Jan 11, 2026, 03:54Unsupervised Machine Learning for Patient Stratification in Cardiovascular Disease
-
Jan 11, 2026, 03:54DAPT De-escalation After PCI․ Where Do We Stand Today?
-
Jan 11, 2026, 03:53Mostafa Faisal Mohammed: Avatrombopag in Aplastic Anemia
-
Jan 11, 2026, 03:52Phil Upton and Paul Cadman at the Plasma Donor Centre in Birmingham: 1500ml Summary Donation!
-
Jan 10, 2026, 15:47Haematologica Journal Presents Review series on von Willebrand Disease
-
Jan 10, 2026, 15:15Stefan Gerner on Stroke Care and Subarachnoid Hemorrhage
-
Jan 10, 2026, 15:02Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
-
Jan 10, 2026, 14:40Last day at ASH25 from Riten Kumar